Zobrazeno 1 - 10
of 180
pro vyhledávání: '"Chafika Mazouni"'
Autor:
Ondine Dufour, Gilles Houvenaeghel, Jean-Marc Classe, Monique Cohen, Christelle Faure, Chafika Mazouni, Marie-Pierre Chauvet, Eva Jouve, Emile Darai, Anne-Sophie Azuar, Pierre Gimbergues, Anthony Gonçalves, Alexandre de Nonneville
Publikováno v:
Breast, Vol 68, Iss , Pp 163-172 (2023)
Background: There is a scarcity of data exploring early breast cancer (eBC) in very young patients. We assessed shared and intrinsic prognostic factors in a large cohort of patients aged ≤35, compared to a control group aged 36 to 50. Methods: Pati
Externí odkaz:
https://doaj.org/article/121ebed073b543aab7c81b276d25f578
Autor:
Gilles Houvenaeghel, Alexandre deNonneville, Nicolas Chopin, Jean‐Marc Classe, Chafika Mazouni, Marie‐Pierre Chauvet, Fabien Reyal, Christine Tunon de Lara, Eva Jouve, Roman Rouzier, Emile Daraï, Pierre Gimbergues, Charles Coutant, Anne Sophie Azuar, Richard Villet, Patrice Crochet, Sandrine Rua, Marie Bannier, Monique Cohen, Jean‐Marie Boher
Publikováno v:
Cancer Medicine, Vol 12, Iss 4, Pp 4023-4032 (2023)
Abstract Background Results of IBCSG‐23‐01‐trial which included breast cancer patients with involved sentinel nodes (SN) by isolated‐tumor‐cells or micro‐metastases supported the non‐inferiority of completion axillary‐lymph‐node‐d
Externí odkaz:
https://doaj.org/article/39181ef7831c4f908a4d040b53e4defe
Autor:
Gilles Houvenaeghel, Eric Lambaudie, Jean-Marc Classe, Chafika Mazouni, Sylvia Giard, Monique Cohen, Christelle Faure, Hélène Charitansky, Roman Rouzier, Emile Daraï, Delphine Hudry, Pierre Azuar, Richard Villet, Pierre Gimbergues, Christine Tunon de Lara, Marc Martino, Jean Fraisse, François Dravet, Marie Pierre Chauvet, Jean Marie Boher
Publikováno v:
BMC Cancer, Vol 19, Iss 1, Pp 1-10 (2019)
Abstract Background A strong correlation between breast cancer (BC) molecular subtypes and axillary status has been shown. It would be useful to predict the probability of lymph node (LN) positivity. Objective: To develop the performance of multivari
Externí odkaz:
https://doaj.org/article/cf5fdd3c49af48848f87f186d0805d5c
Autor:
Muriel Abbaci, Angelica Conversano, Maryam Karimi, Marie-Christine Mathieu, Valérie Rouffiac, Frederic De Leeuw, Stefan Michiels, Corinne Laplace-Builhé, Chafika Mazouni
Publikováno v:
Cancers, Vol 14, Iss 11, p 2614 (2022)
The near-infrared (NIR) fluorescence axillary reverse mapping (ARM) procedure is a promising tool to identify and preserve arm lymphatic drainage during axillary lymph node dissection (ALND). The ARMONIC clinical trial was conducted to validate the t
Externí odkaz:
https://doaj.org/article/16a597abc22b4c638f48fe65103fd4e3
Autor:
Isabelle Miran, Dominique Scherer, Pauline Ostyn, Chafika Mazouni, Françoise Drusch, Marine Bernard, Emilie Louvet, Julien Adam, Marie-Christine Mathieu, Mariam Haffa, Jean-Philippe Antignac, Bruno Le Bizec, Philippe Vielh, Philippe Dessen, Hervé Perdry, Suzette Delaloge, Jean Feunteun
Publikováno v:
Frontiers in Oncology, Vol 10 (2020)
The tissue stroma plays a major role in tumors' natural history. Most programs for tumor progression are not activated as cell-autonomous processes but under the conditions of cross-talks between tumor and stroma. Adipose tissue is a major component
Externí odkaz:
https://doaj.org/article/fc996635f80f4ddd953ef3aedad1bc74
Autor:
Elisabeth Chéreau, Catherine Uzan, Emmanuelle Boutmy-Deslandes, Sarah Zohar, Corinne Bézu, Chafika Mazouni, Jean-Rémi Garbay, Emile Daraï, Roman Rouzier
Publikováno v:
PLoS ONE, Vol 11, Iss 6, p e0156096 (2016)
OBJECTIVE:The aim of this study was to assess the efficacy (response rate centered on 80%) of a somatostatin analog with high affinity for 4 somatostatin receptors in reducing the postoperative incidence of symptomatic lymphocele formation following
Externí odkaz:
https://doaj.org/article/5c198a1168ff414f82fabe7e531dbc86
Autor:
Alexandre Leduey, Chafika Mazouni, Nicolas Leymarie, Heba Alkhashnam, Benjamin Sarfati, Jean-Rémi Garbay, Amélie Gaudin, Frédéric Kolb, Françoise Rimareix
Publikováno v:
International Journal of Breast Cancer, Vol 2015 (2015)
Background. In March 2010, ANSM (Agence Nationale de Sécurité du Medicament), the French Medical Regulatory Authority, withdrew Poly Implant Prothèse (PIP) breast implants from the market due to the use of non-medical-grade silicone gel. The aim o
Externí odkaz:
https://doaj.org/article/17af9944b107483ea9c3061d74db9d02
Autor:
Lajos Pusztai, Gabriel N. Hortobagyi, Bryan T. Hennessy, Massimo Cristofanilli, Chafika Mazouni, Fabrice Andre, Attila Tordai, W. Fraser Symmans, Cornelia Liedtke, Marjorie C. Green, Ana M. Gonzalez-Angulo, Kenneth R. Hess, Jaime A. Mejia
Publikováno v:
Journal of Clinical Oncology. 41:1809-1815
PURPOSE Triple-negative breast cancer (TNBC) is defined by the lack of estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER-2) expression. In this study, we compared response to neoadjuvant chemotherap
Autor:
Gilles Houvenaeghel, Alexandre de Nonneville, Monique Cohen, Jean-Marc Classe, Fabien Reyal, Chafika Mazouni, Christelle Faure, Alejandra Martinez, Marie-Pierre Chauvet, Emile Daraï, Charles Coutant, Pierre-Emmanuel Colombo, Pierre Gimbergues, Anne-Sophie Azuar, Roman Rouzier, Christine Tunon de Lara, Patrice Crochet, Sandrine Rua, Anthony Gonçalves
Publikováno v:
European Journal of Cancer
European Journal of Cancer, 2022, 176, pp.58-69. ⟨10.1016/j.ejca.2022.08.027⟩
European Journal of Cancer, 2022, 176, pp.58-69. ⟨10.1016/j.ejca.2022.08.027⟩
Introduction: Few data have been reported regarding endocrine therapy (ET) in patients with small pT1a-b ER-postive breast cancer (BC). Thus, we conducted a study to detect possible survival improvements due to ET in such patients. Methods: Our retro
Autor:
Lajos Pusztai, W. Fraser Symmans, Gabriel N. Hortobagyi, Bailiang Wang, Jaime Mejia, Chafika Mazouni, Christos Sotiriou, Keith Anderson, Christos Hatzis, Fabrice Andre
Purpose: The clinical outcome for patients with breast cancer is influenced by the metastatic competence of the cancer and its sensitivity to endocrine therapy and chemotherapy. A molecular marker may be prognostic of outcome or predictive of respons
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c461be6f5a2a8a651ab3628e7129850b
https://doi.org/10.1158/1078-0432.c.6518221
https://doi.org/10.1158/1078-0432.c.6518221